Intellia Therapeutics Stock (NASDAQ: NTLA) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 48.00 / 1.52M |
Day Range | - - - |
52 Wk Range | 19.21 - 34.94 |
Market Cap | $2.22B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 48 |
Short Interest | 15.37% |
Days to Cover | 14.02 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Intellia Therapeutics (NASDAQ:NTLA) through any online brokerage.
Other companies in Intellia Therapeutics’s space includes: Twist Bioscience (NASDAQ:TWST), Centessa Pharmaceuticals (NASDAQ:CNTA), SpringWorks Therapeutics (NASDAQ:SWTX), Agios Pharmaceuticals (NASDAQ:AGIO) and Arrowhead Pharma (NASDAQ:ARWR).
Intellia Therapeutics has a consensus price target of $81.36.
The stock price for Intellia Therapeutics (NASDAQ: NTLA) is $21.88 last updated September 20, 2024 at 5:39 PM EDT.
There are no upcoming dividends for Intellia Therapeutics.
Intellia Therapeutics’s Q3 earnings are confirmed for Thursday, November 7, 2024.
There is no upcoming split for Intellia Therapeutics.
Intellia Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.